Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?
| Image |  |
|---|---|
| Description | scientific article published on 26 June 2013 |
| Author/s |
author: Xiao-Jun Huang |
| Publication date | June 26, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |